BYSI

BeyondSpring Inc. BYSI

BYSI
BeyondSpring Inc. APVO
Aptevo Therapeutics Inc. DMAC
DiaMedica Therapeutics Inc. MRKR
Marker Therapeutics, Inc. SNPX
Synaptogenix, Inc. EYEN
Eyenovia, Inc. FULC
Fulcrum Therapeutics, Inc. VRPX
Virpax Pharmaceuticals, Inc. GRTX
Galera Therapeutics, Inc. NRXP
NRx Pharmaceuticals, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BYSI APVO DMAC MRKR SNPX EYEN FULC VRPX GRTX NRXP
6M 57.27 % -91.96 % 100.29 % -3.68 % 134.33 % 675.79 % 229.37 % -95.40 % -32.92 % 52.44 %
YTD 8.81 % -98.22 % 26.13 % -68.80 % 121.75 % -23.23 % 83.06 % -99.88 % -59.85 % 4.52 %
1Y -30.52 % -98.44 % 55.83 % -70.73 % 96.74 % -79.83 % 148.18 % -99.91 % -76.32 % 136.74 %
3Y 86.62 % -100.00 % 351.30 % -68.00 % -95.31 % -96.16 % 12.01 % -100.00 % -99.01 % -59.10 %
5Y -88.71 % -100.00 % 49.14 % -94.02 % -90.87 % -97.43 % -21.87 % -100.00 % -99.87 % -97.10 %
10Y -89.70 % -100.00 % 337.11 % -98.52 % -90.87 % -99.07 % -34.37 % -100.00 % -99.87 % -96.74 %
From the beginning -89.70 % -100.00 % -83.08 % -100.00 % -90.87 % -99.07 % -34.37 % -100.00 % -99.87 % -96.74 %

Dividend